Historical record - last NADAC effective date: 5/22/2024
Product Information
METHYLPHENIDATE ER 20 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $5.9068 per EA under NDC 00591386919. Its NADAC has been published 57 times since Apr 17, 2024.
FDA first approved this application on Dec 13, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591386919
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208861FDA Approved
12/13/2018
TE Code
AB3
On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 20 MG CAP has been published 57 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9068 per EA |
|---|---|
| All-time high | $5.9068 (May 14, 2025) |
| All-time low | $5.9068 (Apr 17, 2024) |
| Median price | $5.9068 |
| Average price | $5.9068 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 57 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 20 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 20 MG CAP, manufactured by Actavis Pharma, Inc., is $5.9068 per EA (NDC 00591386919), effective May 14, 2025.
How has the price of METHYLPHENIDATE ER 20 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 20 MG CAP has held within roughly two percent of its current level. It has been tracked across 57 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 20 MG CAP?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 20 MG CAP has ranged from a low of $5.9068 (Apr 17, 2024) to a high of $5.9068 (May 14, 2025), with a median of $5.9068 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 20 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 20 MG CAP, is $1.4593 per EA — about 75% below METHYLPHENIDATE ER 20 MG CAP.
Who manufactures METHYLPHENIDATE ER 20 MG CAP?
METHYLPHENIDATE ER 20 MG CAP (NDC 00591386919) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.